CD19 monoclonal antibodies
What are CD19 monoclonal antibodies?
CD19 monoclonal antibodies work by targeting the CD19 protein that is present on the surface of pre-B and mature B lymphocytes and overexpressed in several different cancers, including CD19-positive B-cell leukemias or lymphomas.
CD19 monoclonal antibodies may have slightly different ways of working. Some are considered bispecific T-cell engagers, and work by directing T-cells (an important part of our immune system) to target and bind with the CD19 protein that is present on CD19-positive B-cell leukemia or lymphoma cells. Others bind directly to the CD19 antigen and mediate the disintegration and rupture of the B-cell (also called B-cell lysis).
List of CD19 monoclonal antibodies
|Drug Name||Avg. Rating||Reviews|
Generic name: tafasitamab
Generic name: blinatumomab
|For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective).|
Medical conditions associated with CD19 monoclonal antibodies:
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.